Home/ Supplements/ Omega 3/ EPA/DHA Pro Lemon

EPA/DHA Pro Lemon

product on market Liquid Allergy Research Group Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The primary active ingredient, fish oil, provides EPA and DHA omega-3 fatty acids. Strong clinical evidence supports their role in supporting cardiovascular health and managing triglyceride levels. Other listed components are basic nutritional values with no specific therapeutic effect.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for EPA/DHA Pro Lemon
Open Full PDF View on NIH DSLD →
Details

Label Data

5 mL
Serving Size
48
Servings
Fat/Fatty Acid
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
40 Calorie(s)
Calories from Fat
40 Calorie(s)
Total Fat
4 Gram(s)
Protein
1 Gram(s)
4.7 Gram(s)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

D-Mixed Tocopherols Sunflower Oil natural Lemon flavor
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Suggested Use As a dietary supplement, 1 teaspoon daily with meals, or as directed by a healthcare practitioner.

Formulation Notes

High potency fish oil Liquid fish oil, concentrated to 48% long-chain omega-3 fatty acids EPA and DHA, as well as approximately 5% docosapentaenoic acid (DPA). Delicious lemon flavor.

Innovative nutrition

High potency fish oil

Additional Information

Keep in a cool, dry place, tightly capped. Refrigerate after opening.

Friend of the sea Chain of custody IFFO RS Assured Responsible supply

Metadata

Product Details

UPC / SKU7 13947 77500 8
DSLD Entry Date2021-12-18
Product TypeFat/Fatty Acid
FormLiquid
DSLD ID258090
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.